G

Guangdong Marubi Biotechnology Co Ltd
SSE:603983

Watchlist Manager
Guangdong Marubi Biotechnology Co Ltd
SSE:603983
Watchlist
Price: 25.17 CNY 0.92% Market Closed
Market Cap: ¥10.1B

P/E

29.1
Current
33%
Cheaper
vs 3-y average of 43.5

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
29.1
=
Market Cap
¥12.2B
/
Net Income
¥346.7m

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
29.1
=
Market Cap
¥12.2B
/
Net Income
¥346.7m

Valuation Scenarios

Guangdong Marubi Biotechnology Co Ltd is trading below its 3-year average

If P/E returns to its 3-Year Average (43.5), the stock would be worth ¥37.59 (49% upside from current price).

Statistics
Positive Scenarios
3/4
Maximum Downside
-23%
Maximum Upside
+56%
Average Upside
21%
Scenario P/E Value Implied Price Upside/Downside
Current Multiple 29.1 ¥25.17
0%
3-Year Average 43.5 ¥37.59
+49%
5-Year Average 45.5 ¥39.33
+56%
Industry Average 22.4 ¥19.34
-23%
Country Average 29.6 ¥25.62
+2%

Forward P/E
Today’s price vs future net income

Today's Market Cap Net Income Forward P/E
¥12.2B
/
Oct 2025
¥346.7m
=
29.1
Current
¥12.2B
/
Dec 2025
¥393.2m
=
31.1
Forward
¥12.2B
/
Dec 2026
¥424m
=
28.8
Forward
¥12.2B
/
Dec 2027
¥502.2m
=
24.3
Forward

Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.

Peer Comparison

Market Distribution

In line with most companies in China
Percentile
49th
Based on 5 557 companies
49th percentile
29.1
Low
0 — 17.1
Typical Range
17.1 — 57.7
High
57.7 —
Distribution Statistics
China
Min 0
30th Percentile 17.1
Median 29.6
70th Percentile 57.7
Max 43 569.3

Guangdong Marubi Biotechnology Co Ltd
Glance View

Market Cap
10.1B CNY
Industry
Consumer products

Guangdong Marubi Biotechnology Co Ltd stands as a compelling narrative of innovation and heritage in the realm of beauty and skincare. Established in 2002, the company has carved a niche in China’s competitive cosmetics industry by blending advanced biotechnology with traditional skincare practices. This fusion forms the backbone of Marubi’s product portfolio, which spans an array of skincare solutions including anti-aging serums, hydrating masks, and rejuvenating creams. The company’s strength lies in its robust research and development framework, where scientific rigor meets the potential of natural ingredients, leading to the formulation of effective skincare products. By fostering partnerships with renowned research institutions, Marubi ensures that its offerings are not only well-aligned with consumer expectations but also backed by solid scientific evidence. In the financial landscape, Marubi’s operational model is keenly focused on understanding consumer trends and leveraging digital marketing strategies to solidify its market position. A significant portion of the company’s revenues is generated through e-commerce platforms, which tap into China’s rapidly growing online retail market. Emphasizing brand loyalty and customer engagement, Marubi has utilized social media and collaborations with influencers to promote its products and extend its reach beyond traditional retail channels. Moreover, the company has established a keen presence in offline sales, ensuring its brand stands out in both bustling urban centers and emerging local markets. Through this strategic synergy between online and offline sales avenues, Guangdong Marubi Biotechnology Co Ltd thrives as a modern skincare powerhouse, creating value continuously in an ever-evolving market landscape.

Intrinsic Value
37.02 CNY
Undervaluation 32%
Intrinsic Value
Price ¥25.17
G
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett